You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 16 Next »

This example is currently in draft.

This example shows findings from an assessment of the number of mutations within a tumor genome with the purpose of determining likely response to a therapeutic agent. 

Row 1:Shows the number of sequence variants within the region of interest.
Row 2:Shows the normalized number of sequence variants within the region of interest. The panel of genes used in next generation targeted sequencing is shown in SPDVID.
Row 3:Shows the a summary of the magnitude of the variant burden within the tumor. The panel of genes used in next generation targeted sequencing is shown in SPDVID.

gf.xpt

gf.xpt

RowSTUDYIDDOMAINUSUBJIDSPDEVIDGFSEQGFREFIDGFTESTCDGFTESTGFTSTDTLGFORRESGFORRESUGFSTRESCGFSTRESNGFSTRESUGFGENREFGFNAMGFSPECGFMETHODVISITNUMVISITVISITDYGFDTCGFDY
1ABC-123GFABC123-45-001
178975864TMBTumor Mutation BurdenNUMBER OF SEQUENCE VARIANTS497
497497
GRCh37.75Genetics Lab PlusDNAWHOLE EXOME SEQUENCING1SCREENING-12022-01-19-1
2ABC-123GFABC123-45-001ACME 500 GENE PANEL296757855TMBTumor Mutation BurdenNORMALIZED NUMBER OF SEQUENCE VARIANTS8.83/MBP8.838.83/MBPGRCh37.75ACME Genetics Inc.ctDNANEXT GENERATION TARGETED SEQUENCING1SCREENING-12022-01-19-1
3ABC-123GFABC123-45-001ACME 500 GENE PANEL396757855TMBTumor Mutation BurdenVARIANT SEQUENCE BURDEN INTERPRETATIONINTERMEDIATE
INTERMEDIATE

GRCh37.75ACME Genetics Inc.ctDNANEXT GENERATION TARGETED SEQUENCING1SCREENING-12022-01-19-1
$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

  • No labels